ALX Oncology Holdings, Inc. (ALXO)
1.98
-0.01
(-0.50%)
USD |
NASDAQ |
May 22, 16:00
1.985
0.00 (0.00%)
After-Hours: 20:00
ALX Oncology Holdings Shareholders Equity (Quarterly) : 151.35M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 1.013B |
| ADMA Biologics, Inc. | 390.32M |
| Biogen, Inc. | 18.65B |
| Aldeyra Therapeutics, Inc. | 42.16M |
| CytomX Therapeutics, Inc. | 319.94M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 178.33M |
| Total Liabilities (Quarterly) | 26.98M |
| Debt to Equity Ratio | 0.0862 |
| Current Ratio | 7.214 |
| Net Debt Paydown Yield | 0.29% |